Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.49% |
| 2 | Energy | 5.29% |
| 3 | Technology | 4.48% |
| 4 | Financials | 3.44% |
| 5 | Consumer Discretionary | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
CALL
Diana Shipping
DSX
$309M
| $227K | ﹤0.01% |
40,621
+18,022
| +80% | +$128K |
|
|
SFBS
4502
ServisFirst Bancshares
SFBS
$4.99B
| $227K | ﹤0.01% |
16,164
+16,080
| +19,143% | +$233K |
|
|
MGLN
4503
PUT
DELISTED
Magellan Health Services, Inc.
MGLN
| $227K | ﹤0.01% |
+4,200
| New | +$241K |
|
4504
CALL
Adeia
ADEA
$3.29B
| $226K | ﹤0.01% |
32,886
-48,006
| -59% | -$335K |
|
4505
CALL
Ericsson
ERIC
$33.6B
| $226K | ﹤0.01% |
18,800
-187,100
| -91% | -$2.32M |
|
4506
CALL
Gentex
GNTX
$5.03B
| $226K | ﹤0.01% |
17,400
+8,800
| +102% | +$128K |
|
4507
CALL
Interactive Brokers
IBKR
$41.7B
| $226K | ﹤0.01% |
37,600
+23,200
| +161% | +$138K |
|
4508
PUT
Titan Machinery
TITN
$429M
| $226K | ﹤0.01% |
18,800
-5,200
| -22% | -$73.8K |
|
4509
iShares Morningstar Growth ETF
ILCG
$3.29B
| $225K | ﹤0.01% |
10,440
| – | – |
|
4510
PUT
JD.com
JD
$39.2B
| $225K | ﹤0.01% |
+9,000
| New | +$259K |
|
4511
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $225K | ﹤0.01% |
3,000
+800
| +36% | +$61.4K |
|
4512
Silgan Holdings
SLGN
$4.49B
| $225K | ﹤0.01% |
9,542
-5,478
| -36% | -$137K |
|
4513
Stagwell
STGW
$2.23B
| $225K | ﹤0.01% |
11,852
+10,173
| +606% | +$214K |
|
|
CEM
4514
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $225K | ﹤0.01% |
1,660
| – | – |
|
|
SPPI
4515
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $225K | ﹤0.01% |
28,100
+6,300
| +29% | +$49.3K |
|
|
SZYM
4516
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $225K | ﹤0.01% |
31,891
-2,149
| -6% | -$20.1K |
|
|
JTP
4517
DELISTED
NUVEEN QUALITY PFD INCOME FD
JTP
| $225K | ﹤0.01% |
28,084
+84
| +0.3% | +$701 |
|
4518
CALL
Ameren
AEE
$30.4B
| $224K | ﹤0.01% |
5,900
-2,200
| -27% | -$86K |
|
4519
Emcor
EME
$36.9B
| $224K | ﹤0.01% |
5,723
-1,843
| -24% | -$79.2K |
|
4520
ICU Medical
ICUI
$4.58B
| $224K | ﹤0.01% |
3,485
+3,231
| +1,272% | +$198K |
|
|
IMOS
4521
PUT
ChipMOS TECHNOLOGIES
IMOS
$2.03B
| $224K | ﹤0.01% |
9,257
-2,813
| -23% | -$73.9K |
|
4522
United Bankshares
UBSI
$6.71B
| $224K | ﹤0.01% |
7,480
+2,549
| +52% | +$82.2K |
|
|
CQB
4523
CALL
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $224K | ﹤0.01% |
16,000
+10,700
| +202% | +$131K |
|
|
SIVB
4524
CALL
DELISTED
SVB Financial Group
SIVB
| $224K | ﹤0.01% |
2,000
+700
| +54% | +$77.7K |
|
|
CY
4525
DELISTED
Cypress Semiconductor
CY
| $224K | ﹤0.01% |
24,824
-14,735
| -37% | -$155K |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, up from 5% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.